Annual Total Liabilities
$655.30 K
-$464.60 K-41.49%
31 December 2023
Summary:
Protagenic Therapeutics annual total liabilities is currently $655.30 thousand, with the most recent change of -$464.60 thousand (-41.49%) on 31 December 2023. During the last 3 years, it has fallen by -$1.37 million (-67.70%). PTIX annual total liabilities is now -97.28% below its all-time high of $24.11 million, reached on 31 December 2008.PTIX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$789.30 K
+$114.70 K+17.00%
30 September 2024
Summary:
Protagenic Therapeutics quarterly total liabilities is currently $789.30 thousand, with the most recent change of +$114.70 thousand (+17.00%) on 30 September 2024. Over the past year, it has dropped by -$490.80 thousand (-38.34%). PTIX quarterly total liabilities is now -98.06% below its all-time high of $40.64 million, reached on 30 September 2008.PTIX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTIX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.5% | -38.3% |
| 3 y3 years | -67.7% | -38.6% |
| 5 y5 years | -27.8% | +21.2% |
PTIX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -67.7% | at low | -47.6% | +76.9% |
| 5 y | 5 years | -67.7% | at low | -63.8% | +76.9% |
| alltime | all time | -97.3% | +593.4% | -98.1% | +2679.2% |
Protagenic Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $789.30 K(+17.0%) |
| June 2024 | - | $674.60 K(+51.2%) |
| Mar 2024 | - | $446.10 K(-31.9%) |
| Dec 2023 | $655.30 K(-41.5%) | $655.30 K(-48.8%) |
| Sept 2023 | - | $1.28 M(-15.0%) |
| June 2023 | - | $1.51 M(+20.2%) |
| Mar 2023 | - | $1.25 M(+11.8%) |
| Dec 2022 | $1.12 M(+0.2%) | $1.12 M(+28.4%) |
| Sept 2022 | - | $872.30 K(+15.3%) |
| June 2022 | - | $756.40 K(-29.9%) |
| Mar 2022 | - | $1.08 M(-3.5%) |
| Dec 2021 | $1.12 M(-44.9%) | $1.12 M(-13.1%) |
| Sept 2021 | - | $1.29 M(+1.8%) |
| June 2021 | - | $1.26 M(-42.0%) |
| Mar 2021 | - | $2.18 M(+7.4%) |
| Dec 2020 | $2.03 M(+37.4%) | $2.03 M(+0.3%) |
| Sept 2020 | - | $2.02 M(+4.6%) |
| June 2020 | - | $1.93 M(+41.0%) |
| Mar 2020 | - | $1.37 M(-7.1%) |
| Dec 2019 | $1.48 M(+62.7%) | $1.48 M(+126.8%) |
| Sept 2019 | - | $651.00 K(-10.7%) |
| June 2019 | - | $729.20 K(-11.8%) |
| Mar 2019 | - | $826.60 K(-8.9%) |
| Dec 2018 | $907.80 K(+61.6%) | $907.80 K(+36.0%) |
| Sept 2018 | - | $667.40 K(+25.3%) |
| June 2018 | - | $532.50 K(+5.6%) |
| Mar 2018 | - | $504.10 K(-10.3%) |
| Dec 2017 | $561.70 K(-18.0%) | $561.70 K(+4.6%) |
| Sept 2017 | - | $536.90 K(-7.1%) |
| June 2017 | - | $578.10 K(-2.5%) |
| Mar 2017 | - | $592.80 K(-13.4%) |
| Dec 2016 | $684.90 K(-2.7%) | $684.90 K(+5.6%) |
| Sept 2016 | - | $648.30 K(+7.5%) |
| June 2016 | - | $603.10 K(-18.1%) |
| Mar 2016 | - | $736.00 K(-17.5%) |
| Dec 2015 | - | $892.00 K(+16.3%) |
| Sept 2015 | - | $767.00 K(+8.9%) |
| June 2015 | $704.00 K(+122.8%) | $704.00 K(+16.9%) |
| Mar 2015 | - | $602.00 K(+2.2%) |
| Dec 2014 | - | $589.00 K(+35.4%) |
| Sept 2014 | - | $435.00 K(+37.7%) |
| June 2014 | $316.00 K(-98.3%) | $316.00 K(-98.4%) |
| June 2013 | $18.18 M(+62.8%) | - |
| Sept 2011 | - | $19.73 M(+22.2%) |
| June 2011 | - | $16.14 M(+53.2%) |
| Mar 2011 | - | $10.54 M(-5.7%) |
| Dec 2010 | $11.17 M | $11.17 M(-6.7%) |
| Sept 2010 | - | $11.97 M(-18.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | $14.70 M(-16.3%) |
| Mar 2010 | - | $17.56 M(-8.8%) |
| Dec 2009 | $19.25 M(-20.2%) | $19.25 M(-5.4%) |
| Sept 2009 | - | $20.34 M(+6.8%) |
| June 2009 | - | $19.05 M(-20.5%) |
| Mar 2009 | - | $23.95 M(-0.7%) |
| Dec 2008 | $24.11 M(+239.7%) | $24.11 M(-40.7%) |
| Sept 2008 | - | $40.64 M(+9.8%) |
| June 2008 | - | $37.02 M(+1.2%) |
| Mar 2008 | - | $36.56 M(+415.1%) |
| Dec 2007 | $7.10 M(+66.2%) | $7.10 M(-1.0%) |
| Sept 2007 | - | $7.17 M(+56.5%) |
| June 2007 | - | $4.58 M(-7.2%) |
| Mar 2007 | - | $4.94 M(>+9900.0%) |
| Dec 2006 | $4.27 M(+2313.0%) | - |
| Oct 2006 | - | $28.40 K(-84.0%) |
| July 2006 | - | $177.00 K(+2.0%) |
| July 2006 | $177.00 K(+87.3%) | - |
| Apr 2006 | - | $173.50 K(+6.8%) |
| Jan 2006 | - | $162.50 K(+11.1%) |
| Oct 2005 | - | $146.30 K(-98.4%) |
| July 2005 | $94.50 K(-97.8%) | - |
| July 2004 | $4.21 M(-51.3%) | - |
| Apr 2003 | - | $9.15 M(+10.0%) |
| Jan 2003 | - | $8.32 M(-6.7%) |
| Oct 2002 | - | $8.91 M(+3.0%) |
| July 2002 | $8.65 M(-10.8%) | $8.65 M(-2.4%) |
| Apr 2002 | - | $8.87 M(-13.3%) |
| Jan 2002 | - | $10.22 M(-4.3%) |
| Oct 2001 | - | $10.68 M(+10.0%) |
| July 2001 | $9.71 M(+8.5%) | $9.71 M(+0.8%) |
| Apr 2001 | - | $9.63 M(+6.3%) |
| Jan 2001 | - | $9.06 M(+0.7%) |
| Oct 2000 | - | $9.00 M(+0.6%) |
| July 2000 | $8.95 M(-7.4%) | $8.95 M(-1.5%) |
| Apr 2000 | - | $9.08 M(-9.6%) |
| Jan 2000 | - | $10.05 M(+14.2%) |
| Oct 1999 | - | $8.80 M(-8.9%) |
| July 1999 | $9.66 M(+28.3%) | $9.66 M(+9.8%) |
| Apr 1999 | - | $8.80 M(-10.2%) |
| Jan 1999 | - | $9.80 M(+22.5%) |
| Oct 1998 | - | $8.00 M(+6.3%) |
| July 1998 | $7.53 M(+201.2%) | $7.53 M(+10.7%) |
| Apr 1998 | - | $6.80 M(-5.6%) |
| Jan 1998 | - | $7.20 M(+157.1%) |
| Oct 1997 | - | $2.80 M(+12.0%) |
| July 1997 | $2.50 M | $2.50 M(-19.4%) |
| Apr 1997 | - | $3.10 M(+47.6%) |
| Jan 1997 | - | $2.10 M |
FAQ
- What is Protagenic Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Protagenic Therapeutics?
- What is Protagenic Therapeutics annual total liabilities year-on-year change?
- What is Protagenic Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Protagenic Therapeutics?
- What is Protagenic Therapeutics quarterly total liabilities year-on-year change?
What is Protagenic Therapeutics annual total liabilities?
The current annual total liabilities of PTIX is $655.30 K
What is the all time high annual total liabilities for Protagenic Therapeutics?
Protagenic Therapeutics all-time high annual total liabilities is $24.11 M
What is Protagenic Therapeutics annual total liabilities year-on-year change?
Over the past year, PTIX annual total liabilities has changed by -$464.60 K (-41.49%)
What is Protagenic Therapeutics quarterly total liabilities?
The current quarterly total liabilities of PTIX is $789.30 K
What is the all time high quarterly total liabilities for Protagenic Therapeutics?
Protagenic Therapeutics all-time high quarterly total liabilities is $40.64 M
What is Protagenic Therapeutics quarterly total liabilities year-on-year change?
Over the past year, PTIX quarterly total liabilities has changed by -$490.80 K (-38.34%)